{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:21:58Z","timestamp":1773861718624,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02177-7","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:25:56Z","timestamp":1770888356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative diagnostic performance of endoscopic ultrasound, MRI, and CT for preoperative assessment of pancreatic cancer: a Bayesian network meta-analysis under a graded reference standard"],"prefix":"10.1186","volume":"26","author":[{"given":"Hong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinli","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"10","key":"2177_CR1","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3390\/cancers17101607","volume":"17","author":"J Zottl","year":"2025","unstructured":"Zottl J, Sebesta C G, Tomosel E, et al. Unraveling the burden of pancreatic cancer in the 21st Century: trends in incidence, mortality, survival, and key contributing factors . Cancers. 2025;17(10):1607.","journal-title":"Cancers"},{"issue":"20","key":"2177_CR2","doi-asserted-by":"publisher","first-page":"e70318","DOI":"10.1002\/cam4.70318","volume":"13","author":"Z Hesami","year":"2024","unstructured":"Hesami Z, Olfatifar M, Sadeghi A, et al. Global trend in pancreatic cancer prevalence rates through, 2040: an illness-Death modeling study . Cancer Med. 2024;13(20):e70318.","journal-title":"Cancer Med"},{"key":"2177_CR3","doi-asserted-by":"crossref","unstructured":"Mauro A, Faverio C, Brizzi L, et al. Multidisciplinary therapeutic approaches to pancreatic cancer according to the resectability status . J Clin Med. 2025;14(4).","DOI":"10.3390\/jcm14041167"},{"issue":"11","key":"2177_CR4","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","volume":"34","author":"T Conroy","year":"2023","unstructured":"Conroy T, Pfeiffer P, Vilgrain V, et al. Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up . Ann Oncol. 2023;34(11):987\u20131002.","journal-title":"Ann Oncol"},{"issue":"7","key":"2177_CR5","doi-asserted-by":"publisher","first-page":"107670","DOI":"10.4251\/wjgo.v17.i7.107670","volume":"17","author":"X Yang","year":"2025","unstructured":"Yang X, Ge N. Diagnostic value of endoscopic ultrasound in staging of pancreatic cancer . World J Gastrointest Oncol. 2025;17(7):107670.","journal-title":"World J Gastrointest Oncol"},{"key":"2177_CR6","doi-asserted-by":"crossref","unstructured":"Spadaccini M, Franchellucci G, Andreozzi M, et al. Contrast-enhanced harmonic endoscopic ultrasonography for prediction of aggressiveness and treatment response in patients with pancreatic lesions . Cancers (Basel). 2025;17(15).","DOI":"10.3390\/cancers17152545"},{"issue":"8","key":"2177_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/clinpract15080137","volume":"15","author":"L Poggiarelli","year":"2025","unstructured":"Poggiarelli L, Bernetti C, Pugliese L, et al. Manganese-based contrast agents as alternatives to gadolinium: a comprehensive review . Clinics Pract. 2025;15(8):137.","journal-title":"Clinics Pract"},{"issue":"11","key":"2177_CR8","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.7150\/thno.95329","volume":"14","author":"G Metzger","year":"2024","unstructured":"Metzger G, Bayerl C, Rogasch J M, et al. (68)Ga-labeled fibroblast activation protein inhibitor (FAPI) PET\/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapy . Theranostics. 2024;14(11):4184\u201397.","journal-title":"Theranostics"},{"key":"2177_CR9","doi-asserted-by":"crossref","unstructured":"Corallo C, Al-Adhami AS, Jamieson N, et al. An update on pancreatic cancer imaging, staging, and use of the PACT-UK radiology template pre- and post-neoadjuvant treatment . Br J Radiol. 2025, (1165;98:13\u201326.","DOI":"10.1093\/bjr\/tqae217"},{"key":"2177_CR10","doi-asserted-by":"crossref","unstructured":"Rogers HK, Shah S L. Role of endoscopic ultrasound in pancreatic cancer diagnosis and management . Diagn (Basel). 2024;14(11).","DOI":"10.3390\/diagnostics14111156"},{"key":"2177_CR11","doi-asserted-by":"publisher","first-page":"100553","DOI":"10.1016\/j.ejro.2024.100553","volume":"12","author":"C Bilreiro","year":"2024","unstructured":"Bilreiro C, Andrade L, Santiago I, et al. Imaging of pancreatic ductal adenocarcinoma - an update for all stages of patient management . Eur J Radiol Open. 2024;12:100553.","journal-title":"Eur J Radiol Open"},{"issue":"1","key":"2177_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3348\/kjr.2019.0862","volume":"22","author":"H Rhee","year":"2021","unstructured":"Rhee H, Park M-S. The role of imaging in current treatment strategies for pancreatic adenocarcinoma . Korean J Radiol. 2021;22(1):23\u201340.","journal-title":"Korean J Radiol"},{"key":"2177_CR13","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt P M, et al. PRISMA, 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews . Bmj. 2021;372:n160.","journal-title":"Bmj"},{"issue":"4","key":"2177_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"F Mcinnes M D","year":"2018","unstructured":"Mcinnes M D F, Moher D, Thombs B D, et al. Preferred reporting Items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement . Jama. 2018;319(4):388\u201396.","journal-title":"Jama"},{"issue":"11","key":"2177_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell D M, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations . Ann Intern Med. 2015;162(11):777\u201384.","journal-title":"Ann Intern Med"},{"issue":"4","key":"2177_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","volume":"19","author":"MA Tempero","year":"2021","unstructured":"Tempero MA, Malafa MP, M A-H, et al. Pancreatic adenocarcinoma, version 2. 2021, NCCN clinical practice guidelines in Oncology . J Natl Compr Canc Netw. 2021;19(4):439\u201357.","journal-title":"J Natl Compr Canc Netw"},{"issue":"11s","key":"2177_CR17","doi-asserted-by":"publisher","first-page":"S560","DOI":"10.1016\/j.jacr.2017.08.050","volume":"14","author":"A Qayyum","year":"2017","unstructured":"Qayyum A, Tamm E P, Kamel I R, et al. ACR Appropriateness Criteria(\u00ae) staging of pancreatic ductal adenocarcinoma . J Am Coll Radiol. 2017;14(11s):S560\u2013s9.","journal-title":"J Am Coll Radiol"},{"issue":"8","key":"2177_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies . Ann Intern Med. 2011;155(8):529\u201336.","journal-title":"Ann Intern Med"},{"issue":"1","key":"2177_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1148\/radiol.2241010798","volume":"224","author":"Lopez H\u00e4nninen","year":"2002","unstructured":"Lopez H\u00e4nninen, Amthauer H, Hosten N, et al. Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography . Radiology. 2002;224(1):34\u201341.","journal-title":"Radiology"},{"issue":"9225","key":"2177_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0140-6736(00)02479-X","volume":"356","author":"HE Adamek","year":"2000","unstructured":"Adamek HE, Albert J, Breer H, et al. Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study . Lancet. 2000;356(9225):190\u201393.","journal-title":"Lancet"},{"issue":"7","key":"2177_CR21","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1067\/mge.2001.115007","volume":"53","author":"D Becker","year":"2001","unstructured":"Becker D, Strobel D, Bernatik T, et al. Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma . Gastrointest Endosc. 2001;53(7):784\u201389.","journal-title":"Gastrointest Endosc"},{"issue":"10","key":"2177_CR22","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s00259-008-0818-x","volume":"35","author":"V Schick","year":"2008","unstructured":"Schick V, Franzius C, Beyna T, et al. Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound . Eur J Nucl Med Mol Imag. 2008;35(10):1775\u201385.","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"117","key":"2177_CR23","first-page":"1599","volume":"59","author":"M Arabul","year":"2012","unstructured":"Arabul M, Karakus F, Alper E, et al. Comparison of multidetector CT and endoscopic ultrasonography in malignant pancreatic mass lesions . Hepatogastroenterology. 2012;59(117):1599\u2013603.","journal-title":"Hepatogastroenterology"},{"issue":"3","key":"2177_CR24","first-page":"154","volume":"47","author":"V Brimien\u0117","year":"2011","unstructured":"Brimien\u0117 V, Brimas G, Strupas K. Differential diagnosis between chronic pancreatitis and pancreatic cancer: a prospective study of 156 patients . Medicina (Kaunas). 2011;47(3):154\u201362.","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"2177_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.7863\/jum.2006.25.3.363","volume":"25","author":"A S\u0103ftoiu","year":"2006","unstructured":"S\u0103ftoiu A, Popescu C, Cazacu S, et al. Power Doppler endoscopic ultrasonography for the differential diagnosis between pancreatic cancer and pseudotumoral chronic pancreatitis . J Ultrasound Med. 2006;25(3):363\u201372.","journal-title":"J Ultrasound Med"},{"issue":"6","key":"2177_CR26","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2214\/ajr.178.6.1781473","volume":"178","author":"M Imbriaco","year":"2002","unstructured":"Imbriaco M, Megibow A J, Camera L, et al. Dual-phase versus single-phase helical CT to detect and assess resectability of pancreatic carcinoma . AJR Am J Roentgenol. 2002;178(6):1473\u201379.","journal-title":"AJR Am J Roentgenol"},{"issue":"875","key":"2177_CR27","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1259\/bjr.73.875.11144793","volume":"73","author":"A Rieber","year":"2000","unstructured":"Rieber A, Tomczak R, N\u00fcssle K, et al. MRI with mangafodipir trisodium in the detection of pancreatic tumours: comparison with helical CT . Br J Radiol. 2000;73(875):1165\u201369.","journal-title":"Br J Radiol"},{"issue":"7","key":"2177_CR28","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1055\/s-0030-1255537","volume":"42","author":"B Napoleon","year":"2010","unstructured":"Napoleon B, Alvarez-Sanchez M V, Gincoul R, et al. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study . Endoscopy. 2010;42(7):564\u201370.","journal-title":"Endoscopy"},{"key":"2177_CR29","doi-asserted-by":"publisher","first-page":"g 5630","DOI":"10.1136\/bmj.g5630","volume":"349","author":"MA Puhan","year":"2014","unstructured":"Puhan MA, Sch\u00fcnemann H, Murad M H, et al. A GRADE working group approach for rating the quality of treatment effect estimates from network meta-analysis . Bmj. 2014;349:g 5630.","journal-title":"Bmj"},{"key":"2177_CR30","doi-asserted-by":"crossref","unstructured":"Taherian M, Wang H, Wang H. Pancreatic ductal adenocarcinoma: molecular pathology and predictive biomarkers . Cells. 2022;11(19).","DOI":"10.3390\/cells11193068"},{"key":"2177_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/bs.mcb.2024.10.016","volume":"191","author":"G Kanli","year":"2025","unstructured":"Kanli G, Boudissa S, Jirik R, et al. Quantitative pre-clinical imaging of hypoxia and vascularity using MRI and PET . Methods Cell Biol. 2025;191:289\u2013328.","journal-title":"Methods Cell Biol"},{"issue":"1","key":"2177_CR32","doi-asserted-by":"publisher","first-page":"19783","DOI":"10.1038\/s41598-024-70441-3","volume":"14","author":"SA Mohamed","year":"2024","unstructured":"Mohamed SA, Barlemann A, Steinle V, et al. Performance of different CT enhancement quantification methods as predictors of pancreatic cancer recurrence after upfront surgery . Sci Rep. 2024;14(1):19783.","journal-title":"Sci Rep"},{"key":"2177_CR33","doi-asserted-by":"publisher","first-page":"111893","DOI":"10.1016\/j.ejrad.2024.111893","volume":"183","author":"C Qu","year":"2025","unstructured":"Qu C, Zeng P, Hu W, et al. Multiparametric quantitative diffusion weighted magnetic resonance imaging can effectively predict the response to neoadjuvant therapy in borderline resectable pancreatic ductal adenocarcinoma . Eur J Radiol. 2025;183:111893.","journal-title":"Eur J Radiol"},{"key":"2177_CR34","doi-asserted-by":"crossref","unstructured":"Litjens G, Broekmans J, Boers T, et al. Computed tomography-based radiomics using tumor and vessel features to assess resectability in cancer of the pancreatic head . Diagn (Basel). 2023;13(20).","DOI":"10.3390\/diagnostics13203198"},{"key":"2177_CR35","doi-asserted-by":"crossref","unstructured":"Egorov V, Kim P, Dzigasov S, et al. Pancreatectomy with en bloc superior mesenteric vein and all its tributaries resection without PV\/SMV reconstruction for \u201clow\u201d locally advanced pancreatic head cancer . Cancers (Basel). 2024;16(12).","DOI":"10.3390\/cancers16122234"},{"key":"2177_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fphys.2020.00008","volume":"11","author":"L Wang","year":"2020","unstructured":"Wang L, Gaddam S, Wang N, et al. Multiparametric mapping magnetic resonance imaging of pancreatic disease . Front Physiol. 2020;11:8.","journal-title":"Front Physiol"},{"key":"2177_CR37","doi-asserted-by":"crossref","unstructured":"Malagi AV, Shivaji S, Kandasamy D, et al. Pancreatic mass characterization using IVIM-DKI MRI and Machine learning-based multi-parametric texture analysis . Bioeng (Basel). 2023;10(1).","DOI":"10.3390\/bioengineering10010083"},{"key":"2177_CR38","doi-asserted-by":"crossref","unstructured":"Chamokova B, Bastati N, Poetter-Lang S, et al. The clinical value of secretin-enhanced MRCP in the functional and morphological assessment of pancreatic diseases . Br J Radiol. 2018, (1084;91:20170677.","DOI":"10.1259\/bjr.20170677"},{"issue":"5","key":"2177_CR39","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2214\/AJR.20.24857","volume":"216","author":"J Swensson","year":"2021","unstructured":"Swensson J, Zaheer A, Conwell D, et al. Secretin-enhanced MRCP: how and why-AJR Expert panel narrative review . AJR Am J Roentgenol. 2021;216(5):1139\u201349.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2177_CR40","doi-asserted-by":"publisher","first-page":"16603","DOI":"10.1038\/s41598-022-21178-4","volume":"12","author":"E Ohno","year":"2022","unstructured":"Ohno E, Kawashima H, Ishikawa T, et al. The role of EUS elastography-guided fine needle biopsy in the histological diagnosis of solid pancreatic lesions: a prospective exploratory study . Sci Rep. 2022;12(1):16603.","journal-title":"Sci Rep"},{"key":"2177_CR41","doi-asserted-by":"crossref","unstructured":"Mohamed WT, Jahagirdar V, Jaber F, et al. Endoscopic ultrasound-guided fine-needle biopsy versus aspiration for tissue sampling adequacy for molecular testing in pancreatic ductal adenocarcinoma . Cancers (Basel). 2024;16(4).","DOI":"10.3390\/cancers16040761"},{"issue":"7","key":"2177_CR42","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1080\/17474124.2021.1880893","volume":"15","author":"A Facciorusso","year":"2021","unstructured":"Facciorusso A, Mohan B P, Crin\u00f2 S, et al. Contrast-enhanced harmonic endoscopic ultrasound-guided fine-needle aspiration versus standard fine-needle aspiration in pancreatic masses: a meta-analysis . Expert Rev Gastroenterol Hepatol. 2021;15(7):821\u201328.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"2","key":"2177_CR43","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/jgh.13478","volume":"32","author":"A Facciorusso","year":"2017","unstructured":"Facciorusso A, Di Maso M, Serviddio G, et al. Echoendoscopic ethanol ablation of tumor combined with celiac plexus neurolysis in patients with pancreatic adenocarcinoma . J Gastroenterol Hepatol. 2017;32(2):439\u201345.","journal-title":"J Gastroenterol Hepatol"},{"key":"2177_CR44","first-page":"- 2025","volume":"12","author":"X Yu","year":"2025","unstructured":"Yu X, Wang Y, Wang Y, et al. Combining multimodal medical imaging and artificial intelligence for the early diagnosis of pancreatic cancer . Front Med. 2025;12:- 2025.","journal-title":"Front Med"},{"key":"2177_CR45","doi-asserted-by":"publisher","first-page":"1590902","DOI":"10.3389\/fimmu.2025.1590902","volume":"16","author":"S Wu","year":"2025","unstructured":"Wu S, Qin X, Jin Z, et al. A comprehensive review of IgG4-related pancreatitis: pathogenesis, diagnosis, and therapeutic advances . Front Immunol. 2025;16:1590902.","journal-title":"Front Immunol"},{"key":"2177_CR46","doi-asserted-by":"crossref","unstructured":"Nadolska K, Bia\u0142ecka A, Zawada E, et al. Analysis of IVIM perfusion fraction improves detection of pancreatic ductal adenocarcinoma . Diagn (Basel). 2024;14(6).","DOI":"10.3390\/diagnostics14060571"},{"issue":"1","key":"2177_CR47","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12893-025-02938-1","volume":"25","author":"F Abreu De Carvalho L","year":"2025","unstructured":"Abreu De Carvalho L F, F G, Ceelen W, et al. Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRformance): a multicenter prospective trial - trial protocol . BMC Surg. 2025;25(1):204.","journal-title":"BMC Surg"},{"issue":"8","key":"2177_CR48","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.1245\/s10434-025-17407-5","volume":"32","author":"K Omiya","year":"2025","unstructured":"Omiya K, Oba A, Sugiura K, et al. Resectable pancreatic cancer with CA19-9 > 500 U\/mL: A biological indicator for survival benefit with intensive neoadjuvant chemotherapy . Ann Surg Oncol. 2025;32(8):5411\u201320.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"2177_CR49","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1097\/JS9.0000000000001313","volume":"110","author":"J He","year":"2024","unstructured":"He J, Lv N, Yang Z, et al. Comparing upfront surgery with neoadjuvant treatments in patients with resectable, borderline resectable or locally advanced pancreatic cancer: a systematic review and network meta-analysis of randomized clinical trials . Int J Surg. 2024;110(6):3900\u201309.","journal-title":"Int J Surg"},{"key":"2177_CR50","doi-asserted-by":"crossref","unstructured":"Zhang W, Chen J, Zhang W, et al. Advances in endoscopic ultrasound in pancreatic cancer screening, diagnosis, and palliative care . Biomedicines. 2024;13(1).","DOI":"10.3390\/biomedicines13010076"},{"issue":"10","key":"2177_CR51","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3390\/tomography10100117","volume":"10","author":"Y Kurita","year":"2024","unstructured":"Kurita Y, Utsunomiya D, Kubota K, et al. Diagnostic value of contrast-enhanced Dual-energy computed tomography in the pancreatic parenchymal and delayed phases for pancreatic cancer . Tomography. 2024;10(10):1591\u2013604.","journal-title":"Tomography"},{"issue":"4","key":"2177_CR52","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1007\/s00261-024-04605-0","volume":"50","author":"Z Alagic","year":"2025","unstructured":"Alagic Z, Valls Duran C, Suzuki C, et al. Photon-counting detector computed tomography: iodine density versus virtual monoenergetic imaging of pancreatic ductal adenocarcinoma . Abdom Radiol (NY). 2025;50(4):1720\u201330.","journal-title":"Abdom Radiol (NY)"},{"key":"2177_CR53","doi-asserted-by":"publisher","first-page":"670085","DOI":"10.3389\/fonc.2021.670085","volume":"11","author":"Q Liu","year":"2021","unstructured":"Liu Q, Zhang J, Jiang M, et al. Evaluating the histopathology of pancreatic ductal adenocarcinoma by intravoxel incoherent motion-diffusion weighted imaging Comparing with diffusion-weighted imaging . Front Oncol. 2021;11:670085.","journal-title":"Front Oncol"},{"key":"2177_CR54","doi-asserted-by":"crossref","unstructured":"Mayer P, Jiang Y, Kuder T A, et al. Diffusion kurtosis imaging-A superior approach to assess tumor-stroma ratio in pancreatic ductal adenocarcinoma . Cancers (Basel). 2020;12(6).","DOI":"10.3390\/cancers12061656"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02177-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02177-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02177-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:03:04Z","timestamp":1773835384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02177-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2177"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02177-7","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}